Nirmatrelvir and ritonavir treatment significantly reduces the risk of hospitalization and death from COVID-19 in high-risk individuals, according to a recent JAMA Network Open study. However, the treatment’s efficacy varied based on the degree of vulnerability, emphasizing tailored approaches for different risk groups.
Opinion | It’s High Time for Gender-Inclusive Clinical Research
Kim and Wilson are medical students. White men have historically been valued as primary subjects of consensual medical research, therefore harming racial minorities, women, the
July 19, 2023